aspergillosis
ASPERGILLOSIS
Aspergillosis encompasses a variety of clinical syndromes depending on host immunity factors.
It is caused by Aspergillus, an ubiquitous, soil-dwelling, filamentous fungus that grows on soil, food, dead leaves, household dust, etc. It grows best at 37ºC and the small spores are easily inhaled and deposited deep in the lungs.
The most common pathogens are Aspergillus fumigatus, A. flavus, A. niger and A. terreus.
Aspergilloma is a conglomeration of intertwined Aspergillus hyphae, fibrin, mucus and cellular debris within a pulmonary cavity or an ectatic bronchus.

Aspergillosis References

  1. Latgé JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev. 1999 Apr;12(2):310-350. PMID: 10194462
  2. Herbrecht R, Denning DW, Patterson TF, et al; Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002 Aug;374(6):408-415. PMID: 12167683
  3. Reichenberger F, Habicht JM, Gratwohl A, et al. Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients. Eur Respir J. 2002 Apr;19(4):743-755. PMID: 11999005
  4. O’Shaughnessy EM, Forest GN, Walsh TJ. Invasive aspergillosis in patients with hematologic malignancies: recent advances and new challenges. Curr Treat Options Infect Dis. 2003;5:507-515
  5. Limper AH, Knox KS, Sarosi GA, et al; American Thoracic Society Fungal Working Group. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med. 2011 Jan;183(1):96-128. doi: 10.1164/rccm.2008-740ST. PMID: 21193785
  6. Sobel JD. Practice guidelines for the treatment of fungal infections. For the Mycoses Study Group. Infectious Diseases Society of America. Clin Infect Dis. 2000 Apr;30(4):652. PMID: 10770725
  7. Soubani AO, Chandrasekar PH. The clinical spectrum of pulmonary aspergillosis. Chest. 2002 Jun;121(6):1988-1999. PMID: 12065367
  8. Stevens DA, Schwartz hJ, Lee JY, eta al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med. 2000 Mar;342(11):756-762. PMID: 10717010
  9. Stevens DA, Kan VL, Judson MA, et al for Infectious Society of America. Practice guidelines for diseases caused by Aspergillus. Clin Infect Dis. 2000 Apr;30(4):696-709. PMID: 10770732
  10. Walsh T, Anaissie E, Denning D, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008 Feb;46(3):327-360. doi: 10.1086/525258. PMID: 18177225
  11. Tablan OC, Anderson LJ, Besser R, et al. Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep. 2004 Mar;53(6)(Suppl):001-36. PMID: 15048056
  12. Walsh T, Stevens D. Aspergillosis. Goldman's Cecil medicine. 24th ed. Philadelphia: Saunders, an imprint of Elsevier; 2011
  13. Gilbert DN, Moellering RC, Eliopoulos GM, et al. The Sanford guide to antimicrobial therapy. 35th. Hyde Park (VT): Antimicrobial Therapy Inc; 2005.
  14. MedWormhttp://www.medworm.com/rss/index.php/Allergy-%26-Immunology/3/http://www.medworm.com/rss/medicalfeeds/specialities/Allergy-Immunology.xml
  15. MedWormhttp://www.medworm.com/rss/index.php/Respiratory-Medicine/40/http://www.medworm.com/rss/medicalfeeds/specialities/Respiratory-Medicine.xml
  16. Centers for Disease Control and Prevention. Aspergillosis. CDC. https://www.cdc.gov. Jan 2016.
  17. Denning DW, Cadranel J, Beigelman-Aubry C, et al; European Society for Clinical Microbiology and Infectious Diseases and European Respiratory Society. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J. 2016 Jan;47(1):45-68. doi: 10.1183/13993003.00583-2015. PMID: 26699723
  18. Patterson TF, Thompson GR, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2016 Aug;63(4):e1-e60. doi: 10.1093/cid/ciw326. PMID: 27365388
  19. Steinbach WJ. Aspergillosis. In: Cherry JD, Harrison GJ, Kaplan SL, et al. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. 7th. Philadelphia, PA: Saunders, Elsevier Inc; 2014:2704-2722.e5.
  20. Steinbach WJ. Aspergillus. In: Kliegman RM, Stanton BF, St Geme JW, Schor NF, eds. Nelson Textbook of Pediatrics. 20th. Philadelphia, PA: Saunders, Elsevier Inc; 2016:1521-1525.e1.
  21. Akuthota P, Weller PF. Clinical manifestations and diagnosis of allergic bronchopulmonary aspergillosis. UpToDate. https://www.uptodate.com. 24 Mar 2020. Accessed 19 Aug 2020.
  22. Akuthota P, Weller PF. Treatment of allergic bronchopulmonary aspergillosis. UpToDate. https://www.uptodate.com. 1 Jul 2020.
  23. Alastruey-Izquierdo A, Cadranel J, Flick H, et al. Treatment of chronic pulmonary aspergillosis: current standards and future perspectives. Respiration. 2018;96(2):159-170. doi: 10.1159/000489474. PMID: 29982245
  24. Denning DW. Clinical manifestations and diagnosis of chronic pulmonary aspergillosis. UpToDate. https://www.uptodate.com. 24 Apr 2019.
  25. Denning DW. Treatment of chronic pulmonary aspergillosis. UpToDate. https://www.uptodate.com. 30 Jul 2020.
  26. Hage CA, Carmona EM, Epelbaum O, et al. Microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2019 Sep;200(5):535-550. doi: 10.1164/rccm.201906-1185ST. PMID: 31469325
  27. Kauffman CA. Diagnosis of invasive aspergillosis. UpToDate. https://www.uptodate.com. 9 Jul 2019.
  28. Kauffman CA. Epidemiology and clinical manifestations of invasive aspergillosis. UpToDate. https://www.uptodate.com. 14 Aug 2019.
  29. Ullmann AJ, Aguado JM, Arikan-Akdagli S, et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect. 2018 May;24(Suppl 1):e1-e38. doi: 10.1016/j.cmi.2018.01.002. PMID: 29544767
  30. Maertens JA, Girmenia C, Brüggemann RJ, et al. European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukemia. J Antimicrob Chemother. 2018 Dec;73(12):3221-3230. doi: 10.1093/jac/dky286. PMID: 30085172
  31. Maghrabi F, Denning DW. The management of chronic pulmonary aspergillosis: the UK National Aspergillosis Centre approach. Curr Fungal Infect Rep. 2017;11:242-251. doi: 10.1007/s12281-017-0304-7. Accessed 22 Aug 2020. PMID: 29213345
  32. Patel AR, Patel AR, Singh S, et al. Treating allergic bronchopulmonary aspergillosis: a review. Cureus. 2019 Apr;11(4):e4538. doi: 10.7759/cureus.4538. PMID: 31263646
  33. Patterson TF. Treatment and prevention of invasive aspergillosis. UpToDate. https://www.uptodate.com. 18 Jul 2020.
  34. Schlosser RJ, Hamilos DL. Allergic fungal rhinosinusitis. UpToDate. https://www.uptodate.com. 21 May 2020.
  35. Shah A, Panjabi C. Allergic aspergillosis of the respiratory tract. Eur Respir Rev. 2014 Mar;23(131):8-29. doi: 10.1183/09059180.00007413. PMID: 24591658
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
21 Nov 2020
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
Elvira Manzano, 12 May 2020
After months of work disruption, profound worrying, social distancing, and isolation, SARS-CoV-2* still rages on, unyielding to human interventions.
Rachel Soon, 05 Dec 2020

The Malaysian National Immunisation Programme (NIP) will now include a hexavalent combination DTaP-IPV-HiB-HepB vaccine and a pneumococcal vaccine.

Roshini Claire Anthony, 18 Jun 2020

Endorsement of unproven COVID-19 treatments by high-profile public figures led to a drastic increase in the search and purchase of said treatments in the US, according to a research letter published in JAMA.